BioSpace News Archive

Business

Organovo Inks Collaboration Deal to 3D Bioprint Kidney Tissues

The collaboration will focus on expanding the use of 3D bioprinted stem cell-based therapeutic tissues. The goal is to develop treatments for end-stage renal disease.

May 30, 2019
·
3 min read
·
Mark Terry
Business

BioSpace Movers and Shakers, May 31

Biopharma companies from across the globe holster their leadership with new appointments.

May 30, 2019
·
6 min read
·
Alex Keown
Business

Lotus Clinical Research Announces the Addition of Lee Simon and Allan Green

Lotus Clinical Research Announces the Addition of Lee Simon, MD as Principal Advisor, Osteoarthritis Research and Allan Green, MD, PhD, JD as Medical Imaging and Research Advisor

May 30, 2019
·
4 min read
Business

Esperion Announces the Appointment of Tracy M. Woody to Board of Directors

Esperion announced the appointment of Tracy M. Woody as a Class I director, with a term expiring at the 2020 meeting of stockholders.

May 30, 2019
·
7 min read
Business

Coalition of Cancer and Diabetes-Focused Nonprofits Addresses Rare Side Effect of Cancer Treatments

About 1% of patients treated for cancer with checkpoint inhibitors can develop an autoimmune disease similar to Type 1 diabetes.

May 30, 2019
·
3 min read
·
Alex Keown
Business

Johns Hopkins Launches Liquid Biopsy Company with $110 Million Series A

Thrive Earlier Detection Corp., a liquid biopsy company, raised $110 million in Series A funding. The company is launching CancerSEEK, a liquid biopsy test to detect multiple cancers early.

May 30, 2019
·
3 min read
·
Mark Terry
Business

MiMedx Restructures Board, Continues to Dig Out of Financial Mismanagement

M. Kathleen Behrens Wilsey, the current chairwoman of the board at Sarepta Therapeutics, is slated to serve as the next chair of MiMedx.

May 30, 2019
·
2 min read
·
Alex Keown
Business

Hitachi Signs Contract with HIMED Xuzhou City, Jiangsu Province, China to Deliver Particle Therapy System

Hitachi, Ltd. has signed a contract with Himed Hospital Management Co., Ltd., located in Xuzhou City, Jiangsu Province, People’s Republic of China, on May 29 to deliver particle therapy system with capability of irradiating both proton and heavy ion.

May 30, 2019
·
2 min read
Business

IQVIA Global Oncology Trends: An Interview with Murray Aitken

The IQVIA Institute for Human Data Science is releasing its 2019 “Global Oncology Trends” report simultaneously with the American Society of Clinical Oncology (ASCO) Meeting.

May 30, 2019
·
5 min read
·
Mark Terry
Drug Development

Novartis’ Double-Combo Therapy for Asthma Successful in Phase III Trial

Novartis’s QMF149 met its primary and key secondary endpoints in the Phase III QUARTZ clinical trial for asthma. QMF149 is a once-daily, fixed-dose combination therapy containing indacaterol acetate, a long-acting beta agonist, and mometasone furoate, an anti-inflammatory.

May 30, 2019
·
2 min read
·
Mark Terry